CAS, Molecule.one to collaborate on advanced synthesis design technologies

Pallavi Madhiraju- August 12, 2023 0

In a significant development in the realm of drug discovery, CAS, a subsidiary of the American Chemical Society, has teamed up with tech-bio front-runner Molecule.one. ... Read More

Hewlett Packard Enterprise to build TSUBAME4.0 supercomputer for Tokyo Tech

Pallavi Madhiraju- May 20, 2023 0

Hewlett Packard Enterprise (HPE) has been chosen to construct the TSUBAME4.0 by the Tokyo Institute of Technology (Tokyo Tech) Global Scientific Information and Computing Center ... Read More

BioNTech to buy UK-based tech firm InstaDeep for AI-powered drug discovery

Raghuram Kadari- January 11, 2023 0

German biotechnology company BioNTech has agreed to acquire 100% of the remaining InstaDeep shares for an upfront consideration of around £362 million in cash and ... Read More

Equillium acquires Bioniz Therapeutics to expand immunomodulatory drug pipeline

pallavi123- February 16, 2022 0

Equillium, a Nasdaq-listed biotech company, has acquired Bioniz Therapeutics in a deal worth up to around $329 million, in a move to considerably expand its ... Read More

Roivant Sciences enters into $7.3bn merger with Montes Archimedes Acquisition

pallavi123- May 4, 2021 0

Roivant Sciences has agreed to merge with Montes Archimedes Acquisition (MAAC), a Nasdaq-listed special purpose acquisition company, in a deal that values the Swiss biopharma ... Read More

Model Medicines, Sanford Burnham Prebys forge AI-driven drug discovery partnership

pallavi123- March 23, 2021 0

AI drug discovery software company Model Medicines has signed a multi-target collaboration agreement with California-based Sanford Burnham Prebys Medical Discovery Institute for identifying and developing ... Read More

Roivant Sciences to acquire Silicon Therapeutics to boost drug discovery capabilities

pallavi123- February 26, 2021 0

Roivant Sciences has agreed to acquire Silicon Therapeutics, a Boston-based drug design, research, and development company, for $450 million, in an all-share deal. The Swiss ... Read More

Pfizer partners with PostEra to speed up drug discovery using machine learning technology

pharmanewsdaily- December 7, 2020 0

In an exciting new development, Pfizer has teamed up with PostEra, a leading biotech company specializing in machine learning solutions for preclinical drug discovery, to ... Read More

PharmaEngine collaborates with Sentinel Oncology for cancer drug development

pharmanewsdaily- December 6, 2020 0

PharmaEngine, a Taiwanese pharmaceutical company, has entered a strategic collaboration and licensing agreement with UK-based Sentinel Oncology to accelerate the development of a promising new ... Read More

PerkinElmer acquisition of Horizon Discovery Group: A strategic move to enhance genomic and cell engineering capabilities

pharmanewsdaily- November 3, 2020 0

PerkinElmer, a leading US-based provider of life sciences and diagnostics solutions, has announced its acquisition of Horizon Discovery Group, a UK-based company specializing in cell ... Read More

123420 / 34 Posts